The CYP2A13 gene helps make an enzyme that breaks down certain inhaled chemicals, mainly in the nose and lungs. If it does not work well, your body may handle tobacco smoke and other airborne substances differently. Some differences in this gene can change how strongly smoke related chemicals are activated inside cells, which may influence lung cancer risk, especially in people who smoke. This gene is mostly discussed in medical research rather than popular culture.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the information needed to produce proteins, the parts of cells that do much of the work. Others mainly direct when certain processes take place, where they happen, and how strongly they operate. As a group, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find additional information in the LearnHub.
Overview
CYP2A13Gene function
What if the gene works
The CYP2A13 gene helps your body break down nicotine and some other inhaled chemicals. It is most active in tissues lining the nose and airways, where it supports everyday chemical processing.
Risk
What if the gene does not work
When the CYP2A13 gene works less well, airway cells may break down certain inhaled chemicals more poorly. Variants can range from milder to more severe, which can leave enzyme activity partly reduced or largely absent.
Treatment
What does that mean for your treatment
No established treatment or medication choices currently depend on a pathogenic or loss-of-function variant in the CYP2A13 gene. The CYP2A13 gene is being studied as a research biomarker, especially for how airway tissues process tobacco-related chemicals and possible links to lung cancer, but this does not yet guide routine care.
Gene function
What if the gene works
Every day, your airways meet tiny amounts of chemicals from the air you breathe. In cells lining the nose and lungs, the CYP2A13 gene helps start the normal process of changing some of these substances into forms the body can handle. Its work supports routine chemical processing in these tissues.
The CYP2A13 gene is especially active in cells lining the nose and lungs. It helps these tissues begin processing small inhaled chemicals during normal day to day exposure.
Its enzyme attaches oxygen to certain chemicals as an early processing step. This change can make a substance easier for the body to modify further or clear.
After the CYP2A13 gene changes a chemical, other enzymes can often continue the job. This helps explain what the CYP2A13 gene does in the body as part of everyday airway chemical handling.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help make up normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the CYP2A13 gene show how variants influence the CYP2A13 gene's function by altering the enzyme's shape, stability, or ability to process certain chemicals in airway cells. Some milder variants slightly reduce activity or shift which molecules fit into the active site. More severe variants can greatly lower protein levels or leave the enzyme with little or no activity.
How variants are linked to conditions
Current evidence on CYP2A13 gene variants and disease risk is still developing, and the CYP2A13 gene does not yet have a broadly confirmed link to one specific health condition. If you have a reported CYP2A13-related finding, guidance from your doctor or genetic counselor is more useful than general information alone.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and occur widely across the population. Most do not directly affect health and simply contribute to normal human variation. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental influences are involved. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CYP2A13, the clearest risk-related factor is tobacco smoke, especially long-term smoking, because this gene helps process some smoke chemicals in the airways. Some inherited changes in CYP2A13 may alter lung cancer risk, but this varies, and smoke exposure remains the main factor that can raise risk.
Inheritance of CYP2A13 variants
There is not yet a broadly confirmed, disease-specific Mendelian pattern for inheritance of the CYP2A13 gene variants, because this gene is mainly studied for how it may influence risk rather than for causing a single inherited condition on its own. In practical terms, CYP2A13 gene variant inheritance follows the usual pattern for genes on the numbered chromosomes: you inherit one copy from your mother and one copy from your father. The CYP2A13 gene is located on chromosome 19, which is an autosome, so its transmission does not differ between sons and daughters.
What does my CYP2A13 result mean for my family?
There isn't yet a broadly confirmed inheritance pattern tied to a specific health condition for CYP2A13, though this can become clearer as research grows. If you have a specific CYP2A13 result and want to understand what it could mean for relatives, a doctor or genetic counselor can help put it in the right family context.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the CYP2A13 gene, labs usually use a blood or saliva sample. CYP2A13 genetic testing works by reading the DNA code and comparing it with the usual gene sequence to spot variants. Results may list a specific variant or report that no clinically relevant variant was found.
When should I consider getting a genetic test?
There is not yet a broadly established, CYP2A13-specific reason for genetic testing in routine care. Decisions about testing are usually based on your personal and family history and discussed with a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal depends on the condition and the specific type of variant. Many factors, including lifestyle, environment, age, and medical history, also influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help make personal experiences easier to understand.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. One person may break down a drug more quickly, while another may process it more slowly, so the same treatment can feel stronger, weaker, or last for a different amount of time. These inherited differences are common and can influence how well a medicine works or how likely someone is to notice side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medicines. It studies gene-drug patterns to help explain why the same treatment can work differently from one person to another. For many drugs, genes play a part in both how strong a medicine’s effects are and how the body processes it. This information can support more informed, more personalized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the CYP2A13 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so concerns about side effects, new symptoms, or how a treatment is working are best discussed with your doctor.
History
In the late 1990s and early 2000s, researchers identified the CYP2A13 gene while sorting out the closely related CYP2A family of genes. From these first observations, research expanded steadily. Scientists recognized that CYP2A13 was distinct from the better known CYP2A6 gene, which helped clarify why related genes can act differently in different tissues. Early studies drew attention to CYP2A13 because it was found mainly in the respiratory tract, making it relevant to research on inhaled chemicals and smoking related exposures. Over time, descriptions became more precise as genetic and laboratory methods improved. Today, the CYP2A13 gene is mainly discussed in specialist research rather than in public awareness campaigns.